Form 4: IRADIMED Director Receives 1,026 Restricted Stock Units

IRADIMED Corporation's Director, Hilda Scharen-Guivel, was granted 1,026 restricted stock units under the company's 2023 Equity Incentive Plan.

Summary

• Hilda Scharen-Guivel, a Director of IRADIMED Corporation (IRMD), was granted 1,026 Restricted Stock Units (RSUs).
• The grant was made on December 11, 2025, under the company's 2023 Equity Incentive Plan.
• These RSUs will vest in two equal annual installments, beginning on December 11, 2026.
• Upon vesting, each RSU converts into one share of IRADIMED common stock.
• Following this transaction, Hilda Scharen-Guivel beneficially owns 1,932 derivative securities (RSUs).

Sentiment

Score: 6

Explanation: The grant of equity to a director is generally viewed as a neutral to slightly positive event, as it aligns the director's interests with shareholders, but it does not provide new operational or financial performance data.

Positives

• The grant of Restricted Stock Units aligns the Director's interests with those of shareholders, promoting long-term value creation.
• Equity compensation is a standard practice for attracting and retaining qualified board members.

Future Outlook

The granted Restricted Stock Units are scheduled to vest in two equal annual installments, commencing on December 11, 2026, which will result in the conversion of RSUs into common stock.

Industry Context

The grant of Restricted Stock Units to a director is a common form of equity compensation in publicly traded companies, used to incentivize long-term performance and align director interests with shareholder value.

Comparison to Industry Standards

• The use of Restricted Stock Units as a component of director compensation is a widely accepted practice across various industries, aligning with corporate governance best practices for incentivizing long-term commitment and performance.
• Many companies, including peers in the medical device or healthcare technology sector, utilize similar equity incentive plans to compensate non-employee directors.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant aligns the director's long-term interests with shareholder value creation.

Next Steps

• The Restricted Stock Units will vest in two equal annual installments, starting on December 11, 2026.
• Upon vesting, the reporting person will receive shares of common stock.

Key Dates

Keywords

IRMD, Restricted Stock Units, RSU, Insider Transaction, Director Compensation, Equity Incentive Plan